![](/documents/10803/1044530/2M+funding+to+mitigate+COVID-19+impact+on+tuberculosis+services+thumbnail.jpg/6b55bded-9e8b-fac0-2128-e160ba6661fd?t=1601921847330)
$2M funding to mitigate COVID-19 impact on tuberculosis services
Dr. Madhukar Pai launches studies in India, Indonesia, Nigeria and Peru
![](/documents/10803/1056866/Sleep+apnea+treatment+reduces+heart+problems+in+patients+with+prediabetes%2C+a+new+study+finds+thumbnail.jpg/b351cbe2-ec4a-fb2e-104b-992a226e614c?t=1601574765638)
Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds
People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night
![](/documents/10803/1033543/New+study+of+therapy+options+in+metastatic+melanoma_thumbnail.jpg/3afabf48-e435-7107-6605-b3b6b42825f5?t=1600453272777)
New study of therapy options in metastatic melanoma
RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors
![](/documents/10803/1033543/Nip+it+in+the+bud+New+study+will+attack+SARS-Cov2+where+it+multiplies_thumbnail.jpg/6b974138-58e4-d1df-8683-7895cd0478e7?t=1600286412235)
Nip it in the bud: New study will attack SARS-Cov2 where it multiplies
RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening
![](/documents/10803/1033543/Serious+Flaws+in+Studies+Linking+COVID-19+and+Air+Pollution+thumbnail.jpg/cf920de5-399c-197c-2947-40dfd8fb19f7?t=1600108195198)
Serious Flaws in Studies Linking COVID-19 and Air Pollution
Studies have yet to prove this link, say Carleton and McGill University epidemiologists
![](/documents/10803/1033543/Systematic+testing+of+groups+at+increased+risk+of+SARS-CoV-2+an+affordable+and+reasonable+approach+thumbnail.jpg/c4a00945-791d-0d1e-2fec-e45f9f00a213?t=1599747921644)
Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach
In a new cost-analysis study, researchers recommend widespread testing of...
![](/documents/10803/1033543/Old+drug%2C+new+therapy+RI-MUHC-sponsored+phase+III+clinical+trial+ready+to+test+repurposed+dapsone+to+tone+down+lung+inflammation+caused+by+COVID-19+thumbnail.jpg/572e3c50-5118-08f1-5bd6-2a307d306168?t=1599051643192)
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations
![](/documents/10803/1014936/COVID-19+Q%26A+on+dealing+with+pandemic+fatigue+thumbnail.jpg/1022b8b0-0cd6-3b5f-2d5d-edeb5ec1b22c?t=1598978226333)
COVID-19 Q&A on dealing with pandemic fatigue
“We need to strike a balance and take our anxiety down from an unhealthy to a manageable level,” says researcher Jason Harley
![](/documents/10803/1014936/New+study+shows+that+persistence+of+ADHD+into+adulthood+is+an+important+predictor+of+car+crash+risk+thumbnail.jpg/9519fb32-86a5-7452-15b8-281e2b71ed55?t=1598973268150)
New study shows that persistence of ADHD into adulthood is an important predictor of car crash risk
RI-MUHC researcher Dr. Lily Hechtman is senior author of a 20-year study
![](/documents/10803/1000714/Lashanda+Skerritt+awarded+Vanier+Canada+Graduate+Scholarship+thumbnail.jpg/c13440e0-b560-fe74-277a-f5c861ce4a47?t=1598472000944)
Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...